DECADRON W Drug Patent Profile
✉ Email this page to a colleague
When do Decadron W patents expire, and what generic alternatives are available?
Decadron W is a drug marketed by Merck and is included in one NDA.
The generic ingredient in DECADRON W is dexamethasone sodium phosphate; lidocaine hydrochloride. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; lidocaine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DECADRON W?
- What are the global sales for DECADRON W?
- What is Average Wholesale Price for DECADRON W?
Summary for DECADRON W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | DECADRON W at DailyMed |
US Patents and Regulatory Information for DECADRON W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | DECADRON W/ XYLOCAINE | dexamethasone sodium phosphate; lidocaine hydrochloride | INJECTABLE;INJECTION | 013334-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
